Multiple cardiotoxicities during osimertinib therapy.

Saved in:
Bibliographic Details
Title: Multiple cardiotoxicities during osimertinib therapy.
Authors: Kobat H; Department of Pharmacy, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames, UK., Davidson M; Lung Unit, The Royal Marsden NHS Foundation Trust, London, UK., Elkonaissi I; Sheikh Shakhbout Medical City, Abu Dhabi, UAE., Foreman E; Pharmacy Department, The Royal Marsden NHS Foundation Trust, London, UK., Nabhani-Gebara S; Department of Pharmacy, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames, UK.
Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2026 Mar; Vol. 32 (2), pp. 392-398. Date of Electronic Publication: 2023 Mar 21.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1477-092X
DOI:10.1177/10781552231164301